The immune system is complex, dynamic, and absolutely critical to maintain human health. The immune system comprises an enormous breadth of cell types, each able to respond to numerous extracellular environments. We have lacked adequate tools to dissect the mechanisms maintaining immune homeostasis through regulation of diverse cellular identities and stimulation responses. Human genetics has revealed key genes required to prevent immune dysfunction and many genomic loci associated with immune disease1,2. However, natural constraint, statistical power limitations, and lack of causal data hinder genetic association studies, preventing the identification of all key regulators and limiting conclusions about the relationships between regulatory genes 3–5. Experimental manipulation of gene expression with CRISPR provides the ability to investigate the structure and function of immune regulatory systems without the inherent limitations of association studies6.
In the T cell compartment, distinct lineages must respond to diverse signals to mount effective immune responses and maintain homeostasis, but the dynamic regulatory circuits that respond to extracellular cues in primary human cells remain poorly defined. To reveal the regulators of a core immune gene, IL2RA, expressed dynamically across the T cell compartment and required to prevent immune disease, we applied pooled CRISPR KO screens across cellular contexts7–10. We defined critical context specific regulators of IL2RA expression as well as regulators that affect the overall rest and activation state of the cell. One regulator in particular, MED12, coordinated gene regulatory networks required to maintain both T cell rest and activation. CRISPR ablation of MED12 blunted the cell state transitions between rest and activation and protected from activation-induced cell death, revealing a previously unappreciated gene regulatory mechanism governing T cell activity.
The effects of genetic variation on complex traits act mainly through changes in gene regulation. Although many genetic variants have been linked to target genes in cis, the trans-regulatory cascade mediating their effects remains largely uncharacterized. In a separate study, we investigated the function of and relationship between transcription factors associated with immune disease which are categorized as inborn errors of immunity (IEI) genes. We formed a large regulatory network consisting of regulators of IL2RA, IEI genes, and transcription factors without known immune disease associations1,11. These connections revealed shared paths and novel regulatory nodes that enable control over specific immune traits.
As a whole, this thesis work uses gene perturbation in distinct human T cell populations under different conditions to discover critical mechanisms regulating cell type and state specific gene expression. Detailed gene regulatory maps resulting from these studies, coupled with functional immune assays and biochemical data, provide new insights into human genetic variants linked to immune dysfunction and have potential to predict new modification strategies that enhance immunotherapies for the betterment of human health.